606144-05-2 Usage
Uses
Used in Pharmaceutical Industry:
5-(4-bromo-2-chlorophenylamino)-4-fluoro-1-methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]iMidazole-6-carboxamide is used as a potential pharmaceutical agent for its diverse pharmacological activities. 5-(4-broMo-2-chlorophenylaMino)-4-fluoro-1-Methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]iMidazole-6-carboxaMide's unique structure, including the benzimidazole core and various functional groups, suggests its potential use in developing new drugs for treating various diseases and conditions.
Used in Antimicrobial Applications:
In the pharmaceutical industry, 5-(4-bromo-2-chlorophenylamino)-4-fluoro-1-methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]iMidazole-6-carboxamide is used as an antimicrobial agent. Its benzimidazole core and functional groups may exhibit inhibitory effects against various microorganisms, making it a promising candidate for the development of new antimicrobial drugs.
Used in Antiviral Applications:
5-(4-bromo-2-chlorophenylamino)-4-fluoro-1-methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]iMidazole-6-carboxamide is also used as an antiviral agent in the pharmaceutical industry. 5-(4-broMo-2-chlorophenylaMino)-4-fluoro-1-Methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]iMidazole-6-carboxaMide's unique structure may interfere with viral replication and infection processes, offering potential therapeutic benefits in treating viral diseases.
Used in Antitumor Applications:
In the field of oncology, 5-(4-bromo-2-chlorophenylamino)-4-fluoro-1-methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]iMidazole-6-carboxamide is used as an antitumor agent. Its potential to modulate various signaling pathways and exhibit inhibitory effects on tumor growth and progression makes it a promising candidate for the development of new cancer therapies.
Used in Anti-inflammatory Applications:
5-(4-bromo-2-chlorophenylamino)-4-fluoro-1-methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]iMidazole-6-carboxamide is used as an anti-inflammatory agent in the pharmaceutical industry. Its ability to modulate inflammatory processes and alleviate inflammation-related symptoms may contribute to the development of new treatments for various inflammatory diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 606144-05-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,6,1,4 and 4 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 606144-05:
(8*6)+(7*0)+(6*6)+(5*1)+(4*4)+(3*4)+(2*0)+(1*5)=122
122 % 10 = 2
So 606144-05-2 is a valid CAS Registry Number.
606144-05-2Relevant articles and documents
INTERMEDIATES OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE (MAP2K OR MEK) INHIBITORS AND PROCESS FOR THEIR PREPARATION
-
, (2018/04/21)
The present invention relates to intermediates of Mitogen-activated protein kinase kinase (MAP2K or MEK) inhibitors such as Selumetinib, Binimetinib and process for their preparation. The present invention also relates to process for the 5 preparation of MEK inhibitors such as Selumetinib, and Binimetinib.
NOVEL HYDROGEN SULFATE SALT
-
Page/Page column 21, (2008/06/13)
The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation. Compound I
N3 alkylated benzimidazole derivatives as MEK inhibitors
-
Page 10; 23, (2008/06/13)
Disclosed are compounds of the formula I and pharmaceutically acceptable salts and prodrugs thereof, wherein W, R1, R2, R7, R8, R9 and R10 are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed is a method of using such compounds in the treatment of hyperproliferative diseases in mammals, and pharmaceutical compositions containing such compounds.
